The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer-related overall survival for patients on durvalumab for stage III unresectable non–small cell lung cancer with PD-L1 positive and negative tumors.
 
Zohra Nooruddin
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - GlaxoSmithKline
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Corbyn Gilmore
No Relationships to Disclose
 
Amanda Moore
No Relationships to Disclose
 
Elizabeth Burton
Consulting or Advisory Role - Philogen; Replimune
 
Kathleen Franklin
No Relationships to Disclose
 
Xavier Jones
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Lilly (Inst)
 
Kelly Reveles
Employment - Bristol Myers Squibb (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb (I)
Honoraria - Ferring
Consulting or Advisory Role - Ferring
Speakers' Bureau - Ferring
Research Funding - AstraZeneca (Inst)
 
Ion Cotarla
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Atheneum; Capvision; Gerson Lehrman Group; ISR reports; Life Science Strategy Group; M3
 
Daniel Simmons
No Relationships to Disclose
 
Christopher Frei
Research Funding - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst)